Amir Nashat

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Raised $190,000,000.00 from The Kraft Group, Enavate Sciences, Andreessen Horowitz, Gaingels, Polaris Partners, Northpond Ventures and 5AM Ventures.

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Raised $287,000,000.00 from SoftBank Vision Fund, Mirae Asset Capital, Polaris Partners, General Catalyst, Leaps by Bayer, Maverick Ventures, ARCH Venture Partners, NS Investment, Samsara BioCapital and 3E Bioventures.

Polaris Partners is an investment firm that invests in healthcare and biotechnology companies.

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Raised $743,000,000.00 from Polaris Partners, Invus, Redmile Group and Samsara BioCapital.

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Raised $510,499,755.00 from Pfizer Venture Investments, Novo Holdings, Invus, Polaris Partners, ShangPharma, Schrödinger, Timothy A. Springer, SR One, Omega Funds and EcoR1 Capital.

AgBiome - The GENESIS Platform Business is a provider of microbial collection to develop sustainably sourced ingredients.

Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.

Raised $173,000,000.00 from K2 HealthVentures.

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

Raised $620,470,018.00 from Deep Track Capital, Flagship Pioneering, Adage Capital Management, Samsara BioCapital, Blue Owl, Invus, Bain Capital Life Sciences, Dafna Capital Management, Ally Bridge Group and Bain Capital Life Sciences.